Telehealth & Digital Health

Praxis and SEQSTER expand their alliance, leveraging a powerful data platform to speed up development of new treatments for epilepsy and other CNS disorders.

A new campaign from ZOLL LifeVest and the AHA targets the deadly disparity in women's cardiac care, blending advocacy with life-saving wearable technology.

A new liquid biopsy more accurately predicts cancer recurrence than standard methods, offering new hope and clarity for patients after surgery.

Mwyngil Therapeutics starts clinical trials for a novel brain-penetrating drug, aiming to tackle neuroinflammation at its source in MS and Parkinson's.

Activity Connection and Zinnia TV unite to offer an integrated solution, easing staff burnout and enhancing person-centered care for older adults.

A new global survey reveals millions of women are unprepared for menopause's skin impact. One company is now pushing for a new standard in research.

A new membership-based clinic in Beverly Hills promises personalized pelvic care, highlighting a growing trend and a debate over healthcare access and equity.

A new contract lets government agencies bypass RFPs to buy specialized EHRs, aiming to streamline tech adoption and improve inmate care nationwide.

A new partnership aims to train more nurse-midwives, tackling a national healthcare provider shortage and meeting the rising demand for midwifery care.

With a key nod from NCCN guidelines and strong clinical data, high-resolution micro-ultrasound is now a powerful, accessible alternative to MRI.

Laborie's major acquisition brings a life-saving device for postpartum hemorrhage into its portfolio, aiming to reduce maternal deaths worldwide.

CompuGroup Medical's new AI tool aims to slash administrative work, but can it solve the burnout crisis and give doctors back their time with patients?

The wellness app's new podcast, born from personal struggle, offers science-backed advice from top experts in a booming and often confusing industry.

A new partnership gives Texas small business employees free access to a clinically proven virtual program aimed at reversing Type 2 diabetes, not just managing it.

A landmark FDA decision allows Life Biosciences to test its epigenetic reprogramming therapy, ER-100, offering new hope for restoring sight in the blind.

A new SoHo wellness hub uses invisible tech and EEG sensors to read your mind and adapt its environment. But is this the future or a privacy nightmare?

With promising brain scan data, a deep therapeutic pipeline, and a cash runway into 2027, Radiopharm Theranostics is gaining significant momentum.

Stoke Therapeutics' major new lease in Waltham signals a pivotal shift to commercialization and defies a cooling life sciences real estate market.

Omeros begins sales of YARTEMLEA, the first and only approved therapy for TA-TMA, a fatal complication of stem cell transplants, shifting the paradigm.

Myriad Genetics is launching a new cancer test that promises to detect recurrence earlier than ever. But can it win in a competitive market?